Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 24, 2024

BUY
$191.17 - $325.63 $3,249 - $5,535
17 Added 1.35%
1,274 $415,000
Q4 2023

Feb 09, 2024

BUY
$160.99 - $215.69 $26,563 - $35,588
165 Added 15.11%
1,257 $240,000
Q3 2023

Oct 24, 2023

SELL
$194.33 - $283.97 $112,128 - $163,850
-577 Reduced 34.57%
1,092 $217,000
Q2 2023

Jul 13, 2023

SELL
$223.05 - $302.68 $28,550 - $38,743
-128 Reduced 7.12%
1,669 $476,000
Q1 2023

May 11, 2023

BUY
$175.41 - $217.92 $12,629 - $15,690
72 Added 4.17%
1,797 $390,000
Q4 2022

Feb 08, 2023

BUY
$204.38 - $296.82 $4,087 - $5,936
20 Added 1.17%
1,725 $355,000
Q3 2022

Oct 17, 2022

BUY
$195.21 - $310.53 $36,894 - $58,690
189 Added 12.47%
1,705 $474,000
Q1 2022

May 12, 2022

BUY
$127.96 - $207.36 $3,326 - $5,391
26 Added 1.74%
1,516 $314,000
Q4 2021

Feb 03, 2022

BUY
$165.13 - $241.83 $38,805 - $56,830
235 Added 18.73%
1,490 $265,000
Q3 2021

Nov 02, 2021

BUY
$163.99 - $235.57 $28,862 - $41,460
176 Added 16.31%
1,255 $258,000
Q2 2021

Aug 10, 2021

SELL
$131.45 - $201.49 $120,933 - $185,370
-920 Reduced 46.02%
1,079 $204,000
Q1 2021

May 07, 2021

BUY
$92.73 - $142.05 $185,367 - $283,957
1,999 New
1,999 $260,000

Others Institutions Holding SWAV

About Shockwave Medical, Inc.


  • Ticker SWAV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 35,927,100
  • Description
  • ShockWave Medical, Inc., a medical device company, engages in developing and commercializing intravascular lithotripsy technology for the treatment of calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases worldwide. The company offers M5 catheters for treating above-the-knee peripheral artery disease ...
More about SWAV
Track This Portfolio

Track Cambridge Investment Research Advisors, Inc. Portfolio

Follow Cambridge Investment Research Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cambridge Investment Research Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cambridge Investment Research Advisors, Inc. with notifications on news.